229 related articles for article (PubMed ID: 19380485)
1. Dynamin reduces Pyk2 Y402 phosphorylation and SRC binding in osteoclasts.
Bruzzaniti A; Neff L; Sandoval A; Du L; Horne WC; Baron R
Mol Cell Biol; 2009 Jul; 29(13):3644-56. PubMed ID: 19380485
[TBL] [Abstract][Full Text] [Related]
2. Dynamin and PTP-PEST cooperatively regulate Pyk2 dephosphorylation in osteoclasts.
Eleniste PP; Du L; Shivanna M; Bruzzaniti A
Int J Biochem Cell Biol; 2012 May; 44(5):790-800. PubMed ID: 22342188
[TBL] [Abstract][Full Text] [Related]
3. PYK2 autophosphorylation, but not kinase activity, is necessary for adhesion-induced association with c-Src, osteoclast spreading, and bone resorption.
Lakkakorpi PT; Bett AJ; Lipfert L; Rodan GA; Duong LT
J Biol Chem; 2003 Mar; 278(13):11502-12. PubMed ID: 12514172
[TBL] [Abstract][Full Text] [Related]
4. Dynamin forms a Src kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity.
Bruzzaniti A; Neff L; Sanjay A; Horne WC; De Camilli P; Baron R
Mol Biol Cell; 2005 Jul; 16(7):3301-13. PubMed ID: 15872089
[TBL] [Abstract][Full Text] [Related]
5. Novel Role of Src in Priming Pyk2 Phosphorylation.
Zhao M; Finlay D; Zharkikh I; Vuori K
PLoS One; 2016; 11(2):e0149231. PubMed ID: 26866924
[TBL] [Abstract][Full Text] [Related]
6. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA
J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056
[TBL] [Abstract][Full Text] [Related]
7. Convergence of alpha(v)beta(3) integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cgamma in prefusion osteoclasts.
Nakamura I; Lipfert L; Rodan GA; Le T Duong
J Cell Biol; 2001 Jan; 152(2):361-73. PubMed ID: 11266452
[TBL] [Abstract][Full Text] [Related]
8. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility.
Sanjay A; Houghton A; Neff L; DiDomenico E; Bardelay C; Antoine E; Levy J; Gailit J; Bowtell D; Horne WC; Baron R
J Cell Biol; 2001 Jan; 152(1):181-95. PubMed ID: 11149930
[TBL] [Abstract][Full Text] [Related]
9. Abnormal localisation and hyperclustering of (alpha)(V)(beta)(3) integrins and associated proteins in Src-deficient or tyrphostin A9-treated osteoclasts.
Lakkakorpi PT; Nakamura I; Young M; Lipfert L; Rodan GA; Duong LT
J Cell Sci; 2001 Jan; 114(Pt 1):149-160. PubMed ID: 11112699
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin induces podosome disassembly and detachment of osteoclasts by modulating Pyk2 and Src activities.
Shyu JF; Shih C; Tseng CY; Lin CH; Sun DT; Liu HT; Tsung HC; Chen TH; Lu RB
Bone; 2007 May; 40(5):1329-42. PubMed ID: 17321230
[TBL] [Abstract][Full Text] [Related]
11. Src kinase activity is essential for osteoclast function.
Miyazaki T; Sanjay A; Neff L; Tanaka S; Horne WC; Baron R
J Biol Chem; 2004 Apr; 279(17):17660-6. PubMed ID: 14739300
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase epsilon regulates integrin-mediated podosome stability in osteoclasts by activating Src.
Granot-Attas S; Luxenburg C; Finkelshtein E; Elson A
Mol Biol Cell; 2009 Oct; 20(20):4324-34. PubMed ID: 19692574
[TBL] [Abstract][Full Text] [Related]
13. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.
Zhao H; Liu X; Zou H; Dai N; Yao L; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
Cytokine; 2015 Feb; 71(2):199-206. PubMed ID: 25461399
[TBL] [Abstract][Full Text] [Related]
14. Osteoprotegerin disrupts peripheral adhesive structures of osteoclasts by modulating Pyk2 and Src activities.
Zhao H; Liu X; Zou H; Dai N; Yao L; Zhang X; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
Cell Adh Migr; 2016 May; 10(3):299-309. PubMed ID: 26743491
[TBL] [Abstract][Full Text] [Related]
15. The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function.
Horne WC; Sanjay A; Bruzzaniti A; Baron R
Immunol Rev; 2005 Dec; 208():106-25. PubMed ID: 16313344
[TBL] [Abstract][Full Text] [Related]
16. Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway.
Li X; Ye JX; Xu MH; Zhao MD; Yuan FL
Osteoporos Int; 2017 Jul; 28(7):2221-2231. PubMed ID: 28462470
[TBL] [Abstract][Full Text] [Related]
17. (alpha)v(beta)3 integrins and Pyk2 mediate insulin-like growth factor I activation of Src and mitogen-activated protein kinase in 3T3-L1 cells.
Sekimoto H; Eipper-Mains J; Pond-Tor S; Boney CM
Mol Endocrinol; 2005 Jul; 19(7):1859-67. PubMed ID: 15761030
[TBL] [Abstract][Full Text] [Related]
18. Myristoleic acid inhibits osteoclast formation and bone resorption by suppressing the RANKL activation of Src and Pyk2.
Kwon JO; Jin WJ; Kim B; Kim HH; Lee ZH
Eur J Pharmacol; 2015 Dec; 768():189-98. PubMed ID: 26528796
[TBL] [Abstract][Full Text] [Related]
19. The transactivated epidermal growth factor receptor recruits Pyk2 to regulate Src kinase activity.
Schauwienold D; Sastre AP; Genzel N; Schaefer M; Reusch HP
J Biol Chem; 2008 Oct; 283(41):27748-27756. PubMed ID: 18667434
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of osteoclast activation by phloretin through disturbing αvβ3 integrin-c-Src pathway.
Lee EJ; Kim JL; Gong JH; Park SH; Kang YH
Biomed Res Int; 2015; 2015():680145. PubMed ID: 25834823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
